Literature DB >> 12826775

Depression and congestive heart failure.

Thomas P Guck1, Gary N Elsasser, Michael G Kavan, Eugene J Barone.   

Abstract

The prevalence rates of depression in congestive heart failure patients range from 24%-42%. Depression is a graded, independent risk factor for readmission to the hospital, functional decline, and mortality in patients with congestive heart failure. Physicians can assess depression by using the SIG E CAPS + mood mnemonic, or any of a number of easily administered and scored self-report inventories. Cognitive-behavior therapy is the preferred psychological treatment. Cognitive-behavior therapy emphasizes the reciprocal interactions among physiology, environmental events, thoughts, and behaviors, and how these may be altered to produce changes in mood and behavior. Pharmacologically, the selective serotonin reuptake inhibitors are recommended, whereas the tricyclic antidepressants are not recommended for depression in congestive heart failure patients. The combination of a selective serotonin reuptake inhibitor with cognitive-behavior therapy is often the most effective treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12826775     DOI: 10.1111/j.1527-5299.2003.01356.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  22 in total

Review 1.  Management of end stage cardiac failure.

Authors:  Miriam J Johnson
Journal:  Postgrad Med J       Date:  2007-06       Impact factor: 2.401

2.  Prognostic significance of depression in blacks with heart failure: insights from Heart Failure: a Controlled Trial Investigating Outcomes of Exercise Training.

Authors:  Robert J Mentz; Michael A Babyak; Vera Bittner; Jerome L Fleg; Steven J Keteyian; Ann M Swank; Ileana L Piña; William E Kraus; David J Whellan; Christopher M O'Connor; James A Blumenthal
Journal:  Circ Heart Fail       Date:  2015-04-21       Impact factor: 8.790

Review 3.  Depression and Anxiety in Heart Failure: A Review.

Authors:  Christopher M Celano; Ana C Villegas; Ariana M Albanese; Hanna K Gaggin; Jeff C Huffman
Journal:  Harv Rev Psychiatry       Date:  2018 Jul/Aug       Impact factor: 3.732

4.  Depression and cardiovascular disease: healing the broken-hearted.

Authors:  Mary A Whooley
Journal:  JAMA       Date:  2006-06-28       Impact factor: 56.272

Review 5.  Assessing the Quality and Comparative Effectiveness of Team-Based Care for Heart Failure: Who, What, Where, When, and How.

Authors:  Lauren B Cooper; Adrian F Hernandez
Journal:  Heart Fail Clin       Date:  2015-07       Impact factor: 3.179

Review 6.  Diagnosis and treatment of depression in patients with congestive heart failure: a review of the literature.

Authors:  James K Rustad; Theodore A Stern; Kathy A Hebert; Dominique L Musselman
Journal:  Prim Care Companion CNS Disord       Date:  2013-08-15

7.  Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy.

Authors:  Alexandra E Rätz Bravo; Lydia Tchambaz; Anita Krähenbühl-Melcher; Lorenzo Hess; Raymond G Schlienger; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 8.  Measurement of negative thinking in patients with heart failure: a critical review and analysis.

Authors:  Rebecca L Dekker
Journal:  J Cardiovasc Nurs       Date:  2011 Jan-Feb       Impact factor: 2.083

9.  Advantageous Selection, Moral Hazard, and Insurer Sorting on Risk in the U.S. Automobile Insurance Market.

Authors:  Frank A Sloan; Patricia A Robinson; Lindsey M Eldred
Journal:  J Risk Insur       Date:  2016-11-28

Review 10.  Anxiety Disorders and Cardiovascular Disease.

Authors:  Christopher M Celano; Daniel J Daunis; Hermioni N Lokko; Kirsti A Campbell; Jeff C Huffman
Journal:  Curr Psychiatry Rep       Date:  2016-11       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.